|
Cancer Center Support Grant
|
5P30CA013696-38
|
$3,816,425
|
$228,986
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Development of personalized surgical algorithms for muscle-invasive bladder cancer patients
|
5R21CA218976-02
|
$238,815
|
|
ABBOSH, PHILIP
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Glycomics Laboratory for the Development of Ovarian Cancer Biomarkers
|
1U01CA226055-01
|
$768,101
|
|
ABBOTT, KAREN
|
UNIV OF ARKANSAS FOR MED SCIS
|
|
Detection of somatic, subclonal and mosaic CNVs from sequencing
|
1U24CA220242-01A1
|
$559,916
|
|
ABYZOV, ALEXEJ
|
MAYO CLINIC ROCHESTER
|
|
MRI for In Vivo Quantification of Yttrium-90 Microsphere Biodistribution
|
5F31CA150658-02
|
$32,302
|
$32,302
|
Adeyanju, Oyinlolu
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy
|
5R01CA140368-07
|
$369,313
|
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Epigenetic and microenvironmental regulation of dormant disseminated cancer
|
5R01CA218024-02
|
$428,136
|
|
AGUIRRE-GHISO, JULIO
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
CLINICAL TRANSLATION OF 19F MRI TO VISUALIZE CANCER IMMUNOTHERAPEUTIC CELLS
|
4R01CA134633-03
|
$492,130
|
$492,130
|
AHRENS, ERIC
|
CARNEGIE-MELLON UNIVERSITY
|
|
Post-translational control of cancer cell stress response and metastasis
|
5R01CA202027-03
|
$459,505
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
The cohesin complex as a tumor suppressor in myeloid leukemia
|
5R01CA216421-02
|
$511,640
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Comprehensive MRI, MRS and Molecular Analyses: Pten-based Prostate Cancer Models
|
5R01CA129003-05
|
$44,316
|
$44,316
|
ALBANESE, CHRISTOPHER
|
GEORGETOWN UNIVERSITY
|
|
Assessments of Multiple Breast Cancer Biomarkers with Dendritic MRI Probes
|
5K25CA129173-03
|
$131,282
|
$131,282
|
Ali, Md
|
HENRY FORD HEALTH SYSTEM
|
|
Combined Acoustic Imaging and Viscoelastic Parameters Estimation in Breast Cancer
|
1R01CA148994-01A1
|
$423,873
|
$211,937
|
Alizad, Azra
|
MAYO CLINIC
|
|
Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma
|
5U01CA194389-04
|
$632,932
|
|
ALIZADEH, ARASH
|
STANFORD UNIVERSITY
|
|
Hyperbaric oxygen to improve blood count recovery in Auto-HCT for myeloma
|
1R37CA225791-01
|
$358,389
|
|
ALJITAWI, OMAR
|
UNIVERSITY OF ROCHESTER
|
|
Novel Strategies for Precision T-cell Therapies
|
5R01CA198095-03
|
$520,564
|
|
ALMO, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Sensitization to CD47 Blockade to Enhance Anti-Tumor Immunity
|
5F30CA195973-04
|
$49,524
|
|
ANDERSON, KATIE
|
UNIVERSITY OF MINNESOTA
|
|
Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications
|
5R01CA050947-26
|
$301,545
|
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INST
|
|
Rapid Point of Care Detection of HPV-Associated Malignancies
|
5UG3CA211415-02
|
$338,933
|
|
ANDERSON, KAREN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Targeted therapies in mutant BRAF melanoma
|
5R01CA182635-05
|
$321,625
|
|
APLIN, ANDREW
|
THOMAS JEFFERSON UNIVERSITY
|
|
Mutant BRAF-regulated transcription factors in melanoma progression
|
5R01CA196278-04
|
$356,850
|
|
APLIN, ANDREW
|
THOMAS JEFFERSON UNIVERSITY
|
|
Adult Leukemia Research Center
|
2P01CA018029-42A1
|
$3,990,001
|
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Elucidating transcription regulation by epigenetics in neuroblastoma
|
1K08CA226237-01
|
$206,394
|
|
APPLEBAUM, MARK
|
UNIVERSITY OF CHICAGO
|
|
PREDICTING OUTCOME OF EXPERIMENTAL THERAPY IN LYMPHOMAS BY 31P & 1H MRS
|
5R21CA152858-02
|
$169,836
|
$169,836
|
Arias-Mendoza, Fernando
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Long-term Treatment Related CNS Injury in Survivors of Childhood Cancer
|
5R21CA138988-02
|
$178,725
|
$44,681
|
Armstrong, Gregory
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Stanford Cancer Institute
|
5P30CA124435-11
|
$3,334,464
|
$166,723
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Image-guided combination therapy: noninvasive assessment of delivery and response
|
1R01CA154738-01
|
$608,757
|
$608,757
|
ARTEMOV, DMITRI
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer Etiology, Prevention, Detection and Diagnosis
|
2T32CA009302-41
|
$449,025
|
|
ATTARDI, LAURA
|
STANFORD UNIVERSITY
|
|
Post-chemotherapy Symptom Management: Testing Intervention Sequences in a SMART Design
|
1R01CA225615-01
|
$632,908
|
|
BADGER, TERRY
|
UNIVERSITY OF ARIZONA
|
|
Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer
|
1R37CA226969-01
|
$355,706
|
|
BAE-JUMP, VICTORIA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Protein Folding Mechanism
|
ZIA BC 010276
|
$285,604
|
$28,560
|
Bai, Yawen
|
CCR (NCI)
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$275,408
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Training in Translational Tobacco Science
|
5K05CA139871-04
|
$170,073
|
$17,007
|
Baker, Timothy
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Normal and Neoplastic Growth in the Brain
|
5P01CA096832-14
|
$1,999,508
|
|
BAKER, SUZANNE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cooperating Pathways in Gliomagenesis
|
5R01CA188516-05
|
$372,463
|
|
BAKER, SUZANNE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Phase I trial of intravenous vesicular stomatitis virus for treatment of metastatic endometrial cancer
|
5R01CA207240-02
|
$543,708
|
|
BAKKUM-GAMEZ, JAMIE
|
MAYO CLINIC ROCHESTER
|
|
Targeting Brain Tumor Stem Cells In The Hypoxic Microenvironment
|
5R01CA187780-04
|
$362,569
|
|
BAR, ELI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Roles for Intracellular pH Dynamics in Cancer
|
5R01CA197855-03
|
$415,921
|
|
BARBER, DIANE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Targeting the cytokine circuitry of KRAS-driven lung cancer
|
5R01CA190394-04
|
$394,578
|
|
BARBIE, DAVID
|
DANA-FARBER CANCER INST
|
|
Proton MRSI of Human Breast Cancer at 3 and 7 Tesla
|
5R01CA125258-05
|
$354,081
|
$354,081
|
BARKER, PETER
|
JOHNS HOPKINS UNIVERSITY
|
|
Growth Control in Multiple Myeloma
|
5P01CA055819-17
|
$3,653,305
|
$913,326
|
BARLOGIE, BART
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
|
Postdoctoral Research Training in Biotherapy of Cancer
|
2T32CA113263-11
|
$193,203
|
|
BARTLETT, DAVID
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Multiscale Modeling of Bone Environment Responses to Metastatic Prostate Cancer
|
5U01CA202958-03
|
$668,427
|
|
BASANTA GUTIERREZ, DAVID
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Cancer Care Quality Training Program
|
2T32CA116339-11
|
$344,174
|
|
BASCH, ETHAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Clinical and Molecular Studies of Novel Therapeutics in Malignant Brain Tumors
|
5K24CA125440-05
|
$191,011
|
$47,753
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
AZD2171 and chemoradiation for newly diagnosed glioblastoma
|
5R01CA129371-05
|
$607,551
|
$303,776
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Pancreatic Cancer Metastasis
|
1P01CA217798-01A1
|
$1,643,391
|
|
BATRA, SURINDER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
SBIR Topic 266 - A Targeted Nanocomplex for Early Detection of Lung Cancer
|
N43CO900046-003
|
$498,331
|
$498,331
|
BAWA, RAJ
|
SYNERGENE THERAPEUTICS INC:1166661
|
|
Multifunctional Peptides for (MRI) Imaging
|
1R43CA159771-01
|
$186,994
|
$186,994
|
Beattie, Craig
|
CDG THERAPEUTICS, INC.
|
|
Neurocognitive Mechanisms of Decisions and Impulse Control in Nutrition Behavior
|
1R01CA152062-01A1
|
$402,151
|
$402,151
|
BECHARA, ANTOINE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
Total relevant funding to Nuclear Magnetic Resonance Imaging (NMR) for this search: $89,252,734
|